(Q43097113)

13 November 2017

Accuracy of commercial and reference susceptibility testing methods for detecting vancomycin-intermediate Staphylococcus aureus (English)

1 reference

13 November 2017

Staphylococcus aureus

1 reference

1 reference

8

Fred C Tenover

1 reference

13 November 2017

5

Sigrid K McAllister

1 reference

13 November 2017

Jana M Swenson

1

1 reference

13 November 2017

Karen F Anderson

2

1 reference

13 November 2017

David R Lonsway

3

1 reference

13 November 2017

Angela Thompson

4

1 reference

13 November 2017

Brandi M Limbago

6

1 reference

13 November 2017

Roberta B Carey

7

1 reference

13 November 2017

Jean B Patel

9

1 reference

13 November 2017

language of work or name

English

0 references

publication date

6 May 2009

1 reference

Journal of Clinical Microbiology

13 November 2017

1 reference

13 November 2017

47

1 reference

13 November 2017

7

1 reference

13 November 2017

2013-2017

1 reference

Reduced glycopeptide susceptibility in methicillin-resistant Staphylococcus aureus (MRSA).

13 November 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2708520

The rationale for revising the Clinical and Laboratory Standards Institute vancomycin minimal inhibitory concentration interpretive criteria for Staphylococcus aureus

25 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2708520

In vitro activities of daptomycin, vancomycin, linezolid, and quinupristin-dalfopristin against Staphylococci and Enterococci, including vancomycin- intermediate and -resistant strains

25 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2708520

Characterization of staphylococci with reduced susceptibilities to vancomycin and other glycopeptides

25 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2708520

A multicenter study evaluating the current strategies for isolating Staphylococcus aureus strains with reduced susceptibility to glycopeptides

25 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2708520

Spectrum and potency of dalbavancin tested against 3322 Gram-positive cocci isolated in the United States Surveillance Program (2004).

15 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2708520

Daptomycin activity and spectrum: a worldwide sample of 6737 clinical Gram-positive organisms

15 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2708520

15 August 2018

Identifiers

DOI

10.1128/JCM.00221-09

1 reference

13 November 2017

1 reference

13 November 2017

1 reference